Inventor · disambiguated record
Roger A. Sabbadini
Also filed as: SABBADINI ROGER · SABBADINI ROGER A
36 granted patents·43 pending applications·1,222 citations·filing 1998–2018
98Inventor score
Files withSABBADINI ROGER A35LPATH INC18VAXIION THERAPEUTICS INC5MEDLYTE DIAGNOSTICS INC3MEDLYTE INC2
Top patents by PatentIndex Score
79 records- 0198US6534322B1Kits for early detection of heart diseaseMEDLYTE DIAGNOSTICS INC·Filed 2000·Granted Mar 18, 2003·220 cites·16 claims
- 0298US6210976B1Methods for early detection of heart diseaseMEDLYTE DIAGNOSTICS INC·Filed 1998·Granted Apr 3, 2001·295 cites·40 claims
- 0397US7183105B2Eubacterial minicells and their use as vectors for nucleic acid delivery and expressionVAXIION THERAPEUTICS INC·Filed 2002·Granted Feb 27, 2007·90 cites·17 claims
- 0497US6534323B1Compositions and methods for early detection of heart diseaseMEDLYTE DIAGNOSTICS INC·Filed 2000·Granted Mar 18, 2003·211 cites·28 claims
- 0596US9670270B2Minicell based delivery of biologically active compoundsVAXIION THERAPEUTICS LLC·Filed 2015·Granted Jun 6, 2017·14 cites·17 claims
- 0696US9017986B2Minicell based delivery of biologically active compoundsVAXIION THERAPEUTICS INC·Filed 2013·Granted Apr 28, 2015·26 cites·18 claims
- 0796US8524484B2Immunogenic minicells and methods of useSABBADINI ROGER A·Filed 2012·Granted Sep 3, 2013·27 cites·7 claims
- 0895US8129166B2Immunogenic minicells and methods of useSABBADINI ROGER A·Filed 2008·Granted Mar 6, 2012·19 cites·8 claims
- 0995US8101396B2Minicells displaying antibodies or derivatives thereof and comprising biologically active compoundsSABBADINI ROGER A·Filed 2007·Granted Jan 24, 2012·27 cites·3 claims
- 1095US6858383B2Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic thereforMEDLYTE INC·Filed 2001·Granted Feb 22, 2005·81 cites·22 claims
- 1194US7871815B2Rhamnose-inducible expression constructs and methodsVAXIION THERAPEUTICS INC·Filed 2006·Granted Jan 18, 2011·14 cites·2 claims
- 1294US6881546B2Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic thereforMEDLYTE INC SDSU HEART INST·Filed 2001·Granted Apr 19, 2005·72 cites·20 claims
- 1393US7829674B2Compositions and methods for binding sphingosine-1-phosphateLPATH INC·Filed 2007·Granted Nov 9, 2010·20 cites·6 claims
- 1491US7169390B2Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammationLPATH THERAPEUTICS INC·Filed 2004·Granted Jan 30, 2007·39 cites·2 claims
- 1589US8614103B2Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditionsSABBADINI ROGER A·Filed 2007·Granted Dec 24, 2013·6 cites·9 claims
- 1689US7901682B2Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammationLPATH INC·Filed 2006·Granted Mar 8, 2011·9 cites·7 claims
- 1787US7396822B2Immunogenic minicells and methods of useVAXIION THERAPEUTICS INC·Filed 2004·Granted Jul 8, 2008·12 cites·25 claims
- 1886US8158124B2Compositions and methods for binding lysophosphatidic acidSABBADINI ROGER A·Filed 2008·Granted Apr 17, 2012·10 cites·10 claims
- 1985US8025877B2Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphateLPATH INC·Filed 2008·Granted Sep 27, 2011·5 cites·18 claims
- 2084US8796429B2Bioactive lipid derivatives, and methods of making and using sameSABBADINI ROGER A·Filed 2007·Granted Aug 5, 2014·2 cites·6 claims
- 2184US8067549B2Humanized antibodies and compositions for binding sphingosine-1-phosphateSABBADINI ROGER A·Filed 2008·Granted Nov 29, 2011·4 cites·12 claims
- 2283US8444970B2Compositions and methods for treating ocular diseases and conditionsSABBADINI ROGER A·Filed 2007·Granted May 21, 2013·2 cites·11 claims
- 2382US8604172B2Humanized antibody compositions and methods for binding lysophosphatidic acidSABBADINI ROGER A·Filed 2010·Granted Dec 10, 2013·5 cites·5 claims
- 2481US9274130B2Prevention and treatment of pain using antibodies to lysophosphatidic acidSABBADINI ROGER A·Filed 2011·Granted Mar 1, 2016·4 cites·4 claims
- 2579US8026342B2Compositions and methods for binding sphingosine-1-phosphateLPATH INC·Filed 2008·Granted Sep 27, 2011·2 cites·11 claims
- 2676US8871202B2Prevention and treatment of pain using antibodies to sphingosine-1-phosphateSABBADINI ROGER A·Filed 2011·Granted Oct 28, 2014·2 cites·4 claims
- 2776US8222373B2Humanized antibodies and compositions for binding sphingosine-1-phosphateSABBADINI ROGER A·Filed 2008·Granted Jul 17, 2012·1 cites·8 claims
- 2875US9217749B2Immune-derived moieties reactive against lysophosphatidic acidSABBADINI ROGER A·Filed 2007·Granted Dec 22, 2015·1 cites·5 claims
- 2973US7862812B2Methods for decreasing immune response and treating immune conditionsLPATH INC·Filed 2007·Granted Jan 4, 2011·1 cites·13 claims
- 3072US8401799B2Antibody design using anti-lipid antibody crystal structuresSABBADINI ROGER A·Filed 2010·Granted Mar 19, 2013·1 cites·7 claims
- 3168US2009004744A1Minicells as vaccinesVAXIION THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3267US7956173B2Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphateLPATH INC·Filed 2008·Granted Jun 7, 2011·0 cites·17 claims
- 3363US2012135503A1Minicell based delivery of biologically active compoundsSABBADINI ROGER A·Filed 2011·Application pending·0 cites
- 3462US2012142079A1Minicell based delivery of biologically active compoundsSABBADINI ROGER A·Filed 2011·Application pending·0 cites
- 3561US9163091B2Compositions and methods for binding lysophosphatidic acidSABBADINI ROGER A·Filed 2009·Granted Oct 20, 2015·0 cites·6 claims
- 3661US2003194798A1Minicell compositions and methodsFiled 2002·Application pending·0 cites
- 3758US2015031055A1Novel bioactive lipid derivatives, and methods of making and using the sameLPATH INC·Filed 2014·Application pending·0 cites
- 3858US2015203570A1Prevention and treatment of pain using antibodies to sphingosine-1-phosphateLPATH INC·Filed 2014·Application pending·0 cites
- 3957US2017254822A1Methods and kits for detecting and diagnosing neurotraumaSABBADINI ROGER A·Filed 2016·Application pending·0 cites
- 4057US2008213274A1Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eyeSABBADINI ROGER A·Filed 2007·Application pending·0 cites
- 4157US2013302831A1Methods and kits for detecting and diagnosing neurotraumaSABBADINI ROGER A·Filed 2013·Application pending·0 cites
- 4256US2009220523A1Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditionsLPATH INC·Filed 2006·Application pending·0 cites
- 4356US2007148168A1Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditionsSABBADINI ROGER A·Filed 2006·Application pending·0 cites
- 4456US2013261287A1Antibody design using anti-lipid antibody crystal structuresSABBADINI ROGER A·Filed 2013·Application pending·0 cites
- 4556US2005226862A1Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders and for identifying agents therapeutic thereforMEDLYTE INC·Filed 2005·Application pending·0 cites
- 4655US2018298111A1Prevention and treatment of pain using antibodies to lysophosphatidic acidAPOLLO ENDOSURGERY INC·Filed 2018·Application pending·0 cites
- 4752US7794713B2Compositions and methods for the treatment and prevention of hyperproliferative diseasesLPATH INC·Filed 2005·Granted Sep 14, 2010·0 cites·9 claims
- 4851US2012195901A1Compositions and Methods for Binding Lysophosphatidic AcidSABBADINI ROGER A·Filed 2012·Application pending·0 cites
- 4951US2014199293A1Humanized antibody compositions and methods for binding lysophosphatidic acidLPATH INC·Filed 2013·Application pending·0 cites
- 5051US2006002956A1Minicells as vaccinesSURBER MARK W·Filed 2005·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roger A. Sabbadini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →